Differences in slope, in years, between the indicated groups for cognitive and gross motor development
| Groups . | Cognitive development . | Gross motor development . | ||
|---|---|---|---|---|
| βdiff . | P . | βdiff . | P . | |
| Asymptomatic vs untreated | 0.92 | <.001 | 0.69 | <.001 |
| Asymptomatic vs symptomatic >12 mo | 0.63 | <.001 | 0.67 | <.001 |
| Asymptomatic vs symptomatic ≤12 | 0.86 | <.001 | 0.67 | <.001 |
| Symptomatic >12 mo vs untreated | 0.29 | .016 | −0.02 | .85 |
| Symptomatic ≤12 vs untreated | 0.06 | .65 | −0.01 | .92 |
| Symptomatic >12 mo vs symptomatic ≤12 | 0.23 | .11 | −0.01 | .97 |
| Groups . | Cognitive development . | Gross motor development . | ||
|---|---|---|---|---|
| βdiff . | P . | βdiff . | P . | |
| Asymptomatic vs untreated | 0.92 | <.001 | 0.69 | <.001 |
| Asymptomatic vs symptomatic >12 mo | 0.63 | <.001 | 0.67 | <.001 |
| Asymptomatic vs symptomatic ≤12 | 0.86 | <.001 | 0.67 | <.001 |
| Symptomatic >12 mo vs untreated | 0.29 | .016 | −0.02 | .85 |
| Symptomatic ≤12 vs untreated | 0.06 | .65 | −0.01 | .92 |
| Symptomatic >12 mo vs symptomatic ≤12 | 0.23 | .11 | −0.01 | .97 |